Pharmaceutical Analysis & Statistics in Oceania Countries, May 2013 (p8)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

You might be interested in: therapeutics, drug, cancer, more »

211-260 of about 400 reports

Purchase Reports From Reputable Market Research Publishers

Dilated Cardiomyopathy - Pipeline Review, H1 2014

Dilated Cardiomyopathy - Pipeline Review, H1 2014

  • $ 2 000
  • Company report
  • June 2014
  • by Global Markets Direct

Dilated Cardiomyopathy - Pipeline Review, H1 2014 Summary Global Markets Direct's, ‘Dilated Cardiomyopathy - Pipeline Review, H1 2014', provides an overview of the Dilated Cardiomyopathy's therapeutic ...

  • Industries : Pathology
  • Countries : World, Australia
Physiotherapy Services Market in Australia

Physiotherapy Services Market in Australia

  • $ 965
  • Industry report
  • June 2014
  • by Ibisworld

IBISWORLD This is the replacement for IBISWorld's October Physiotherapy Services in Australia About this Market This market research report from IBISWorld provides a in-depth overview of the Physiotherapy ...

  • Industries : Therapy
  • Countries : Australia
Sienna Cancer Diagnostics Ltd - Product Pipeline Analysis, 2014 Update

Sienna Cancer Diagnostics Ltd - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • June 2014
  • by Global Data

Summary Sienna Cancer Diagnostics Ltd. (Sienna) is a biotechnology company. The company commercializes diagnostic tests for the purpose of monitoring, diagnosing and evaluation of the progression of cancer. ...

  • Industries : Pathology
  • Countries : Australia
Sigma Pharmaceuticals Ltd in Retailing (Australia)

Sigma Pharmaceuticals Ltd in Retailing (Australia)

  • $ 153
  • Company report
  • June 2014
  • by Euromonitor International

After a successful redefinition of its business strategy, Sigma Pharmaceuticals has been focusing on strengthening its pharmacy-based retail business. In the first quarter of 2013, Sigma Pharmaceuticals ...

  • Industries : E-commerce, Pharmaceutical
  • Countries : Australia
MarketVIEW - Chikungunya vaccines

MarketVIEW - Chikungunya vaccines

  • $ 3 995
  • Industry report
  • June 2014
  • by VacZine Analytics Group Of Assay Advantage Ltd

Chikungunya virus is an arthropod-borne RNA virus (arbovirus) which causes an acute illness including fever, skin rash, and incapacitating arthralgia. In some cases the virus can cause recurrent disease, ...

  • Industries : Drug and Medication
  • Countries : India, Japan, China, Asia, Papua New Guinea, World, United States, Bhutan, Guinea, Africa, Laos
Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Seroquel XR (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia
Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Brexpiprazole (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom, Oceania
Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Cariprazine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania
ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

ALKS-5461 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania
Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Amitifadine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania
GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

GLYX-13 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania
PharmaPoint: Major Depressive Disorder - Australia Drug Forecast and Market Analysis to 2023

PharmaPoint: Major Depressive Disorder - Australia Drug Forecast and Market Analysis to 2023

  • $ 4 995
  • Industry report
  • May 2014
  • by Global Data

PharmaPoint: Major Depressive Disorder - Australia Drug Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market ...

  • Industries : Pathology
  • Countries : Australia
Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Tedatioxetine (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan
Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Lexapro (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania
ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

ETS6103 (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, United States, United Kingdom, Europe, Oceania
Viibryd (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Viibryd (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Viibryd (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : United States, Australia, World
PharmaPoint: Major Depressive Disorder - Current and Future Players

PharmaPoint: Major Depressive Disorder - Current and Future Players

  • $ 2 995
  • Industry report
  • May 2014
  • by Global Data

PharmaPoint: Major Depressive Disorder - Current and Future Players Summary GlobalData has released its pharma report, “PharmaPoint: Major Depressive Disorder - Current and Future Players”. The report ...

  • Industries : Pathology
  • Countries : World, Australia
Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Effexor (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, United States, Spain, Italy, France, Germany, United Kingdom, Europe, Oceania
Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Cymbalta (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, Japan, World, Spain, Italy, France, Germany, United States, United Kingdom, Europe, Oceania
Pristiq (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Pristiq (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Pristiq (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia
Fetzima (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Fetzima (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Fetzima (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : United States, World, Australia, Canada
Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Brintellix (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, World, Spain, Italy, France, Germany, Japan, Europe, United States, United Kingdom, Oceania
Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023

Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023

  • $ 3 495
  • Industry report
  • May 2014
  • by Global Data

Abilify (Major Depressive Disorder) - Forecast and Market Analysis to 2023 Summary Major depressive disorder (MDD) is one of the most common psychiatric diseases worldwide. The MDD market is a crowded ...

  • Industries : Pathology
  • Countries : Australia, Japan, World, Spain, Italy, France, Germany, United States, United Kingdom, Europe, Oceania
CSL Limited - Strategy and SWOT Report

CSL Limited - Strategy and SWOT Report

  • $ 175
  • Company report
  • May 2014
  • by MarketLine

CSL Limited - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and ...

  • Industries : Therapy
  • Countries : Australia
Hospira, Inc. (HSP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Hospira, Inc. (HSP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Hospira, Inc. (Hospira) is a global specialty pharmaceutical and medication delivery company. The company undertakes the development, manufacturing, and marketing of products that help improve ...

  • Industries : Pharmaceutical
  • Countries : Australia, World, United States, Japan, India
Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Starpharma Holdings Limited (SPL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • May 2014
  • by Global Data

Summary Starpharma Holdings Limited (Starpharma) develops dendrimer products for pharmaceutical, life science and other applications. It has three development programs namely, VivaGel portfolio, drug delivery ...

  • Industries : Pharmaceutical
  • Countries : Australia
World Drug and Medication: Nausea – Pipeline Review, H1 2012

World Drug and Medication: Nausea – Pipeline Review, H1 2012

  • $ 2 000
  • Industry report
  • May 2014
  • by Global Markets Direct

This report provides data on the therapeutic development for Nausea, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in ...

  • Industries : Drug Discovery and Development
  • Countries : World, Australia
Sigma Pharmaceuticals Limited (Symbol:SIP) SWOT Analysis, Strategy, Revenues and Profits

Sigma Pharmaceuticals Limited (Symbol:SIP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • May 2014
  • by Global Data

Sigma Pharmaceuticals Limited (Sigma) is an Australian pharmaceutical company. Sigma is principally engaged in marketing, wholesale and retail distribution of pharmaceutical products through the pharmacy ...

  • Industries : Pharmaceutical
  • Countries : Australia
Vitamin and Provitamin Markets in the World to 2018 - Market Size, Trends, and Forecasts

Vitamin and Provitamin Markets in the World to 2018 - Market Size, Trends, and Forecasts

  • $ 22 464
  • Industry report
  • May 2014
  • by Global Research & Data Services

The expansion of the global vitamin and provitamin industry is forecast to reach 2.6% p.a. in the coming years. Between 2007 and 2013 the market increased with an average annual growth of 8.0%. Currently, ...

  • Industries : Vitamin and Supplement
  • Countries : United States, World, Europe, Asia, South America, North America, Czech Republic, South Korea, Philippines, Netherlands, Singapore, Panama, Slovenia, Slovakia (slovak Republic), Belgium, Japan, India, China, Australia, Argentina, United Kingdom, Macedonia, Lithuania, Sri Lanka, Kazakhstan, Indonesia, Azerbaijan, South Africa, Africa, Uruguay, Ecuador, Chile, Colombia, Bolivia, Mexico, Canada, Ukraine, Sweden, Spain, Russian Federation, Romania, Portugal, Poland, Norway, Moldova, Republic Of, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Bulgaria, Austria, Vietnam, Thailand, Pakistan, Malaysia, Lebanon, Jordan, Georgia, Armenia, Senegal, Nigeria, Morocco, Ghana, Ethiopia, Egypt
Vitamin and Provitamin Market in Australia to 2018 - Market Size, Trends, and Forecasts

Vitamin and Provitamin Market in Australia to 2018 - Market Size, Trends, and Forecasts

  • $ 652
  • Industry report
  • May 2014
  • by Global Research & Data Services

This industry report offers the most up-to-date market data on the actual market situation, trends and future outlook for vitamins and provitamins in Australia. The research includes historic market data ...

  • Industries : Vitamin and Supplement
  • Countries : Australia
About 3 300 reports

Download Unlimited Documents from Trusted Public Sources

Drug And Medication Analysis in Australia - Forecast

  • Abstract Introduction: Secondary Prevention Drugs for Cardiac
  • October 2014
    12 pages
  • Drug And Medica...  

    Drug  

  • Australia  

View report >

1 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.